European Archives - Page 559 of 1561 - European Medical Journal

Persistent DNA Lesions Contribute to Mutations Over Time

A study reveals DNA lesions that persist in stem cells, contributing to mutations, with implications for blood cancers.

New Study Highlights Benefits of Sotagliflozin in Type 1 Diabetes with CKD

Sotagliflozin offers significant benefits for individuals with Type 1 diabetes and chronic kidney disease, study finds.

Innovative Approach to Treat Severe Cow’s Milk Allergy

A recent study explored a baked milk oral immunotherapy protocol for children with severe cow’s milk allergy.

Janet Abrahm

Onc Now: Episode 9: The Power of Palliative Care

Janet Abrahm, Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute breaks stigmas around palliative care and supportive oncology.

3D Printing Revolutionises Neurogenic Bladder Surgery

A recent study introduced a novel approach combining preoperative 3D printing with intraoperative ultrasound-guided puncture to address challenges in neurogenic bladder surgery.

Phase 2 Trial Results: TAK-071 Enhances Cognition in Parkinson’s Disease

TAK-071 enhances cognition in Parkinson’s disease but doesn’t reduce gait variability, phase 2 trial results reveal.

New Model Predicts Gastrointestinal Lesions in Eosinophilic Granulomatosis with Polyangiitis

A new study develops a model to predict gastrointestinal lesions in eosinophilic granulomatosis, highlighting eosinophils as a critical risk factor.

Cardiovascular Disease Increases Risk of Advanced Breast Cancer

Advanced breast cancer patients are likelier to have pre-existing cardiovascular disease, urging integrated screening strategies for early detection.

Longer Rescreening Intervals After Negative Colonoscopy for Low-Risk Individuals

A study suggests extending colonoscopy rescreening beyond 10 years for low-risk individuals, based on long-term colorectal cancer outcomes.

Increased ME/CFS Risk in Adults Post-COVID-19

The ongoing RECOVER-Adult study reveals that myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) develops significantly more frequently following SARS-CoV-2 infection.